BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18281368)

  • 1. Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab.
    McGonagle D; Tan AL; Madden J; Rawstron AC; Rehman A; Emery P; Thomas S
    Rheumatology (Oxford); 2008 Apr; 47(4):552-3. PubMed ID: 18281368
    [No Abstract]   [Full Text] [Related]  

  • 2. Discordant response to rituximab in a systemic sclerosis patient with associated myositis.
    Fabri M; Hunzelmann N; Krieg T; Rubbert A
    J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S127-8. PubMed ID: 18489049
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal exacerbation of fibrosing alveolitis associated with systemic sclerosis in a patient treated with adalimumab.
    Allanore Y; Devos-François G; Caramella C; Boumier P; Jounieaux V; Kahan A
    Ann Rheum Dis; 2006 Jun; 65(6):834-5. PubMed ID: 16699057
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of interstitial pulmonary fibrosis with D-penicillamine in progressive scleroderma: a long-term study (author's transl)].
    Bröll H; Tausch G; Eberl R
    Wien Klin Wochenschr; 1976 Apr; 88(9):292-5. PubMed ID: 973388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulse cyclophosphamide decreases sympathetic postganglionic activity, controls alveolitis, and normalizes vascular tone dysfunction (Raynaud's phenomenon) in a case of early systemic sclerosis.
    Casale R; Generini S; Luppi F; Pignone A; Matucci-Cerinic M
    Arthritis Rheum; 2004 Aug; 51(4):665-9. PubMed ID: 15334442
    [No Abstract]   [Full Text] [Related]  

  • 6. Cystic lung disease in systemic sclerosis: a case report with high resolution computed tomography findings.
    Bergemann A; Tikly M
    Rev Rhum Engl Ed; 1996 Mar; 63(3):213-5. PubMed ID: 8731240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of D-penicillamine on pulmonary fibrosis in patients with systemic sclerosis.
    Jinnin M; Ihn H; Asano Y; Yamane K; Yazawa N; Tamaki K
    Ann Rheum Dis; 2003 Oct; 62(10):1019-20. PubMed ID: 12972489
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary complications: one of the most challenging complications of systemic sclerosis.
    Wells AU; Steen V; Valentini G
    Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii40-4. PubMed ID: 19487223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide therapy for scleroderma.
    Akesson A
    Curr Opin Rheumatol; 1998 Nov; 10(6):579-83. PubMed ID: 9812219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis.
    Hellmann M; Jung N; Owczarczyk K; Hallek M; Rubbert A
    Rheumatology (Oxford); 2008 Jun; 47(6):929-30. PubMed ID: 18411212
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of rituximab on resistant SLE disease including lung involvement.
    Reynolds JA; Toescu V; Yee CS; Prabu A; Situnayake D; Gordon C
    Lupus; 2009 Jan; 18(1):67-73. PubMed ID: 19074171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment with leflunomide of arthritis in systemic sclerosis patients.
    Sebastiani M; Giuggioli D; Vesprini E; Caruso A; Ferri C
    Rheumatology (Oxford); 2006 Sep; 45(9):1175-6. PubMed ID: 16820378
    [No Abstract]   [Full Text] [Related]  

  • 13. Rituximab for treatment of scleritis associated with rheumatoid arthritis.
    Chauhan S; Kamal A; Thompson RN; Estrach C; Moots RJ
    Br J Ophthalmol; 2009 Jul; 93(7):984-5. PubMed ID: 19553514
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of Sjogren's syndrome with rituximab.
    Touma Z; Sayad J; Arayssi T
    Scand J Rheumatol; 2006; 35(4):323-5. PubMed ID: 16882600
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful use of rituximab in a patient with recalcitrant Churg-Strauss syndrome.
    Kaushik VV; Reddy HV; Bucknall RC
    Ann Rheum Dis; 2006 Aug; 65(8):1116-7. PubMed ID: 16837496
    [No Abstract]   [Full Text] [Related]  

  • 16. Effective treatment of refractory pulmonary hemorrhage with monoclonal anti-CD20 antibody (rituximab).
    Pinto LF; Candia L; Garcia P; Marín JI; Pachón I; Espinoza LR; Marquez J
    Respiration; 2009; 78(1):106-9. PubMed ID: 18799870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with rituximab of autoimmune haemolytic anaemia causing dialysis-dependent acute renal failure.
    Brown CE; Traynor JP; Sharp RA; Fox JG
    Nephrol Dial Transplant; 2007 Sep; 22(9):2730-1. PubMed ID: 17575312
    [No Abstract]   [Full Text] [Related]  

  • 18. Rituximab and antineutrophil cytoplasmic antibody-associated vasculitis: granulomatous disease more resistant than vasculitis disease?
    Wong CF
    J Clin Rheumatol; 2008 Apr; 14(2):61-4. PubMed ID: 18391671
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of rituximab in Felty's syndrome.
    Lekharaju V; Chattopadhyay C
    Ann Rheum Dis; 2008 Sep; 67(9):1352. PubMed ID: 18697782
    [No Abstract]   [Full Text] [Related]  

  • 20. Refractory severe connective tissue disease thrombocytopenia: is rituximab treatment effective and safe?
    Zheng WJ; Zhang X; Wang Q; Xu D; Zeng XF; Zhang FC
    Ann Rheum Dis; 2009 Jun; 68(6):1077-8. PubMed ID: 19435726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.